NASDAQ:VTGN

Vistagen Therapeutics Stock News

Healthcare > Biotechnology

Buy VTGN

*Your capital is at risk

$0.560

-0.0199 (-3.43%)

At Close: Jun 03, 2026

How Vistagen (VTGN) Stock Stands Out in a Strong Industry

09:46am, Friday, 29'th Dec 2023

Vistagen (VTGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond

06:24pm, Friday, 22'nd Dec 2023

Positive results achieved in phase 3 PALISADE-2 study for Fasedienol, a potential new treatment for social anxiety disorder. It is estimated that there are roughly 25 million people in the United Stat

Vistagen Therapeutics, Inc. (VTGN) Q2 2024 Earnings Call Transcript

10:12am, Friday, 10'th Nov 2023

Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Mark McPartland - Senior Vice President, Investor Relations Shawn Singh - C

The 7 Best Short-Squeeze Stocks to Buy Now: September 2023

04:43pm, Thursday, 21'st Sep 2023

The best short-squeeze stocks to buy now can be a perilous territory in the investment landscape. However, they also possess the potential for astronomical returns.

Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript

05:24am, Sunday, 13'th Aug 2023

Vistagen Therapeutics, Inc. (NASDAQ:VTGN ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Mark Flather - VP of IR Shawn Singh - CEO Josh Prince - SVP of Business Oper

Outperforming Biotech Pops on Shareholder Buzz

10:32am, Thursday, 10'th Aug 2023

Vistagen Therapeutics Inc (NASDAQ:VTGN) is continuing its recent volatility, after today's news that healthcare investment name Commodore Capital Master LP has become a top shareholder with a 19.7% st

Why Is Vistagen Therapeutics (VTGN) Stock Up 650% Today?

03:59pm, Monday, 07'th Aug 2023

Vistagen Therapeutics (NASDAQ: VTGN ) stock is surging to impressive levels today on news of some positive trial results. The pharmaceutical producer has been struggling all year, dipping into penny s

2 Biotech Stocks Staging Large Swings

02:32pm, Monday, 07'th Aug 2023

Sage Therapeutics Inc (NASDAQ:SAGE) is crumbling to record lows today, down 52.2% at $17.25 at last check, earlier hitting a low of $16.69.

VistaGen Therapeutics (VTGN Stock) Exploded 3,471% Here's Why

09:58am, Monday, 07'th Aug 2023

Are you looking for penny stocks to buy? Are you grappling with the push and pull of skeptics saying penny stocks aren't worth it or penny stocks are a scam?

Vistagen to Announce Fiscal Year 2023 Financial Results and Provide Corporate Update Conference Call on June 28, 2023

04:30pm, Tuesday, 27'th Jun 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individua

Vistagen to Present at Jefferies 2023 Global Healthcare Conference

04:30pm, Tuesday, 06'th Jun 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individua

Vistagen to Present Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

04:15pm, Tuesday, 30'th May 2023

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by